Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Vectus Biosystems Limited

VBS

----

OverviewOverview NewsNews PostsPosts

LongbridgeAI

XORTX discloses US$240,000 finder’s fees tied to Vectus renal program acquisition after omission
PUBT·Aug 28 at 11:01 AM
XRTX-13.31%
Vectus Biosystems Seeks ASX Quotation for 7.9 Million New Shares
Tip Ranks·May 27 at 02:07 AM
Vectus Biosystems Grants 981,000 Unquoted Options Under Employee Scheme
Tip Ranks·May 8 at 05:33 AM
Vection Technologies Seeks ASX Quotation for 66.9 Million New Shares
Tip Ranks·Apr 9 at 01:18 AM
Voolt SA - Raport roczny
Polish Emitent·Mar 23 at 08:52 PM
BioVersys Cleared By FDA To Begin Phase 3 Trial Of BV100 For Drug-Resistant Hospital Pneumonia
nasdaq·Mar 16 at 08:25 AM